Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mankind Pharma Ltd. ( (IN:MANKIND) ) has shared an update.
Mankind Pharma Ltd. has received an ESG rating of ‘Crisil ESG 57’ from Crisil ESG Ratings & Analytics Limited, indicating an ‘adequate’ level of environmental, social, and governance practices. This rating reflects the company’s efforts in maintaining transparency and responsibility in its operations, potentially impacting its reputation and attractiveness to investors focused on sustainable practices.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of a wide range of healthcare products. The company is known for its commitment to providing affordable and quality medicines, catering to both domestic and international markets.
Average Trading Volume: 19,120
Technical Sentiment Signal: Strong Buy
Current Market Cap: 1028.3B INR
See more data about MANKIND stock on TipRanks’ Stock Analysis page.